1-2 of 2
Merry Zhai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R 2 -CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study

Annalisa Chiappella, Thomas E. Witzig, MD, Kim Cocks, Mike Greenwood, Abi Williams, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD, Kazuhito Yamamoto, Wojciech Jurczak, Muhit Özcan, David Belada, Juan Miguel Bergua Burgues, Francesco Piazza, Carlo Visco, Gerardo Musuraca, MD, Sandra Margunato-Debay, Myron Czuczman, Merry Zhai, Julia Braverman, Umberto Vitolo, Grzegorz Nowakowski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3475.
https://doi.org/10.1182/blood-2019-123948
Published: 2019
Journal Articles

A Phase I, Open Label, Multicenter Trial of Oral Azacitidine (CC-486) Plus R-CHOP in Patients with High-Risk, Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma

Peter Martin, MD, Nancy L. Bartlett, MD, Ildefonso Ismael Rodriguez Rivera, MD, Maria Revuelta, PhD, Julio C. Chavez, MD, John L. Reagan, MD, Sonali M. Smith, MD, Ann S. LaCasce, MD, Lei Zhang, MD, Merry Zhai, BS, Chengqing Wu, PhD, John P. Leonard, MD, Leandro Cerchietti, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 192.
https://doi.org/10.1182/blood.V130.Suppl_1.192.192
Published: 2017